Panacea Biotec Limited (NSE:PANACEABIO)
India · Delayed Price · Currency is INR 400.00
-6.90 (-1.70%)
Oct 1, 2025, 3:30 PM IST
Panacea Biotec Market Cap
Panacea Biotec has a market cap or net worth of 24.56 billion as of October 2, 2025. Its market cap has increased by 26.14% in one year.
Market Cap
24.56B
Enterprise Value
23.64B
Revenue
6.10B
Ranking
n/a
PE Ratio
213.72
Stock Price
400.00
Market Cap Chart
Since April 1, 2002, Panacea Biotec's market cap has increased from 21.08B to 24.56B, an increase of 16.54%. That is a compound annual growth rate of 0.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2025 | 24.56B | -4.20% |
| Dec 31, 2024 | 25.64B | 149.32% |
| Dec 29, 2023 | 10.28B | 18.20% |
| Dec 30, 2022 | 8.70B | -28.49% |
| Dec 31, 2021 | 12.17B | -17.07% |
| Dec 31, 2020 | 14.67B | 82.44% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,825.26B |
| Divi's Laboratories | 1,512.51B |
| Cipla | 1,214.30B |
| Apollo Hospitals Enterprise | 1,070.33B |
| Mankind Pharma | 1,016.21B |
| Zydus Lifesciences | 988.02B |
| Fortis Healthcare | 732.88B |
| Alkem Laboratories | 646.73B |